Superior Performance, Reliable Results

Detect known and novel fusions with Fusions, a partner-agnostic FFPE RNA-based multiplex amplicon assay.

Imagia Canexia Health’s Fusions panel is designed to target a set of 17 genes and 59 exons that are key in diagnosis, prognosis, and approved therapeutic options in solid adult tumors.

ALK2, 10, 16-22
BRAF2, 6-12,15,19
EGFR1-3, 7-9,11, 13,16, 20-21, 24-25, 27, 8, 23
FGFR11-10, 14,17
FGFR22, 8-10,13, 16-17
FGFR32-4, 8-10, 16-18
MET2-6, 13-17, 21
NRG11, 1-8
NTRK12, 7-13
NTRK37, 12-18
RAF12, 8-10
RET2-4, 7-13
Turnaround time3 to 5 days
Reproducibility100% (same input replicates), 91.67% (including replicates with different input


Actionable Results

A targeted set of 17 genes and 59 exons that are key in diagnosis, prognosis, and approved therapeutic options in solid adult tumors.

Rapid Turnaround Time

A simple laboratory workflow that provides rapid, reliable, results.

Comprehensive Reports

Review detailed interpretations, current treatment options, and available clinical trials.


Targeted amplicon-based technology provides an economical alternative to single-gene testing or hybrid capture NGS assays.

Conserve Biopsy Tissue

Imagia Canexia Health Fusions assay allows for simultaneous hotspot testing, reducing the amount of biopsy tissue required, when compared to single-gene testing.


All Imagia Canexia Health assays and software are developed in our CLIA, CAP, CDPH and DAP accredited laboratory.

View Other Solutions

Plasma Follow It®

Imagia Canexia Health’s Follow It panel detects mutations in plasma. Plasma profiling (a type of liquid biopsy) can be used to help tailor treatment, monitor cancer progression, or detect treatment resistance.

Learn About Follow It


Imagia Canexia Health’s Find It & Fusions panels detect mutations and gene fusion events in solid tumor tissue. Tissue profiling can be used to help inform treatment decisions or predict progression of cancer based on somatic mutations found in the tumor.

Learn About Tissue Assays

Imagia Canexia Health Insights Platform

Each comprehensive report includes detailed results as well as therapeutic recommendations and expertly curated clinical trials. Our insights can help make more informed treatment decisions.

Learn About Our Reports

Your Information On Your Servers

Perform world-leading mutation assays, right from your laboratory: Imagia Canexia Health’s proprietary bioinformatics platform covers everything from mutation identification to auto-generated clinical reports.

Learn More

Do More From Your Own Lab

Imagia Canexia Health’s expert and cost-effective assays, informatics, and support mean rapid assay results. Learn how partnering with Imagia Canexia can help you bring precision oncology in-house.

Get Started Today